Private Equity

Updated:

Velan Capital

Velan Capital is a healthcare-focused investment firm founded in 2017 in New York, New York. The company specializes in investment services for the healthcare...

Velan Capital logo

Velan Capital

Velan Capital is a healthcare-focused investment firm founded in 2017 in New York, New York. The company specializes in investment services for the healthcare sector. It has made one investment, in Tenax Therapeutics, as part of a PIPE - III on August 06, 2024.

General information

Firm type

Private Equity

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Frequently asked questions

What investment strategy does Velan Capital pursue?

Velan Capital executes a control buyout strategy focused on middle-market companies in North America. The firm targets businesses with defensible market positions where it can drive value through operational improvements and strategic repositioning. Typical deal types include founder transitions and corporate carve-outs.

How does Velan Capital typically structure its investments?

Velan pursues control equity investments, acquiring majority stakes in target companies. The firm positions itself to influence operating decisions directly rather than holding minority passive positions. Its capital base is expected to come from committed blind-pool funds raised from institutional limited partners.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Private Equity profiles